FESTI, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 198
EU - Europa 166
AS - Asia 162
SA - Sud America 23
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 555
Nazione #
US - Stati Uniti d'America 193
SG - Singapore 74
RU - Federazione Russa 62
CN - Cina 49
IT - Italia 22
BR - Brasile 21
DE - Germania 21
HK - Hong Kong 21
FR - Francia 13
SE - Svezia 13
IE - Irlanda 12
GB - Regno Unito 7
FI - Finlandia 6
KR - Corea 6
IN - India 4
AT - Austria 3
CA - Canada 3
BE - Belgio 2
JP - Giappone 2
MA - Marocco 2
MX - Messico 2
PL - Polonia 2
TG - Togo 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CO - Colombia 1
ES - Italia 1
KE - Kenya 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 555
Città #
Singapore 35
Chandler 28
Hong Kong 20
Dallas 19
Ashburn 18
Moscow 16
New York 15
Beijing 13
Dublin 12
Jacksonville 6
Munich 6
Redondo Beach 6
Southend 6
Bologna 5
Lawrence 5
Princeton 5
Frankfurt am Main 4
Guangzhou 4
Sindelfingen 4
Turku 4
Verona 4
Ann Arbor 3
Hebei 3
Jinan 3
Los Angeles 3
Nanjing 3
Nuremberg 3
Phoenix 3
Shenyang 3
Vancouver 3
Wilmington 3
Bari 2
Brooklyn 2
Brussels 2
Delhi 2
Denver 2
Lomé 2
Ningbo 2
Redmond 2
Santa Clara 2
Seattle 2
São Paulo 2
Warsaw 2
Anapa 1
Aracruz 1
Atlanta 1
Belo Horizonte 1
Buzău 1
Camaçari 1
Central 1
Charlotte 1
Chennai 1
Chicago 1
Colorado 1
Columbus 1
Cruz Alta 1
Curitiba 1
Fes 1
Formigueiro 1
Fuzhou 1
Haikou 1
Hamanocho 1
Hangzhou 1
Helsinki 1
Huzhou 1
Itajaí 1
Jubail 1
Jundiaí 1
Kent 1
Lahore 1
Lancaster 1
Lappeenranta 1
Las Vegas 1
Macaé 1
Manassas 1
Manila 1
McKenzie 1
Meknes 1
Mercês 1
Milan 1
Mumbai 1
Nairobi 1
Natal 1
Norwalk 1
Orem 1
Petrolândia 1
Querétaro 1
Quận Ninh Kiều 1
Redwood City 1
Rio Grande 1
Rio de Janeiro 1
Riohacha 1
Rome 1
Saltillo 1
San Diego 1
San Fernando 1
Shenzhen 1
St Louis 1
São Bernardo do Campo 1
São Gabriel da Palha 1
Totale 346
Nome #
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 104
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 93
Relevance of TH2 markers in the assessment and therapeutic management of severe allergic asthma: A real-life perspective 82
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 80
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy 79
One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response 77
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 52
Totale 567
Categoria #
all - tutte 2.751
article - articoli 2.751
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 7 2 0 0 0 0 2 0
2021/202243 11 11 1 5 0 0 1 2 2 2 1 7
2022/202393 8 5 12 8 11 19 3 4 17 1 3 2
2023/202451 4 4 4 6 3 14 4 1 1 0 9 1
2024/2025161 18 8 9 16 7 5 6 8 27 8 16 33
2025/2026177 34 23 23 73 24 0 0 0 0 0 0 0
Totale 567